AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

ISRG · NASDAQ · Medical - Instruments & Supplies

Intuitive Surgical (ISRG)

Builds robotic surgical and lung-biopsy platforms with procedure-linked instruments and service.

$401.95

After hours+0.06 (+0.01%)

At close$401.89(+0.06%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	1,744	1,928	1,891	2,010	2,038	2,414	2,253	2,440	2,505	2,866	2,771	2,892
Cost of revenue	577	651	645	637	664	771	796	822	843	962	940	932
Gross profit	1,167	1,277	1,245	1,373	1,374	1,642	1,458	1,618	1,662	1,904	1,831	1,960
	701	827	776	805	797	907	880	875	903	1,040	975	989
Research & development	249	260	285	280	286	295	316	313	329	353	362	371
Selling, general & administrative	452	567	492	525	511	613	563	561	573	687	613	618
Operating income	466	450	469	567	577	735	578	743	760	864	855	972
	56	66	69	87	94	75	90	89	96	91	85	83
Interest income	56	66	69	87	94	75	90	89	96	91	85	85
Other non-operating income	0	−66	−69	−87	−94	−75	−90	−89	−96	−91	−85	−2
Income before tax	522	516	539	655	671	810	669	832	855	956	940	1,055
Income tax expense	102	−95	−9	123	100	122	−35	168	146	156	114	231
Net income from continuing operations	420	611	547	532	571	688	704	664	709	800	826	823
Net income	416	606	545	527	565	686	698	658	704	795	822	818
EPS, basic	$1.18	$1.72	$1.54	$1.48	$1.59	$1.92	$1.95	$1.84	$1.98	$2.24	$2.31	$2.32
EPS, diluted	$1.16	$1.69	$1.51	$1.46	$1.56	$1.88	$1.92	$1.81	$1.95	$2.21	$2.28	$2.35
Weighted average shares, basic	352	352	354	355	356	356	358	359	357	355	355	355
Weighted average shares, diluted	358	358	361	361	363	364	365	364	362	360	360	359
EBITDA	574	639	648	766	787	935	809	987	1,015	1,177	1,140	1,174
Depreciation & amortization	109	123	109	112	116	125	141	155	160	221	200	200
EBIT	466	516	539	655	671	810	669	832	855	956	940	974